# Pulmatrix, Inc.: filings

PULM · Nasdaq · CIK 1574235 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pulm.md) · [Financials](/companies/pulm/financials.md) · [Filings](/companies/pulm/filings.md) · [Insiders](/companies/pulm/insiders.md)

## Reports and events: 294 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 192, 4 110, 10-Q 37, 3 26, CORRESP 26, 424B3 20, EFFECT 16, SC 13G 15, SC 13G/A 15, UPLOAD 15, D 14, DEFA14A 14, 10-K 13, 424B5 12, S-1/A 12, DEF 14A 11, 425 9, S-8 9, SC 13D/A 8, S-4/A 7, S-1 6, S-3 6, 10-K/A 5, 4/A 5, 8-K/A 5, FWP 4, SC 13D 4, 424B4 3, ARS 3, CT ORDER 3, S-3/A 3, S-4 3, DRS 2, POS AM 2, PRE 14A 2, 424B2 1, 8-A12B 1, CERTNAS 1, DEFM14A 1, POS EX 1, RW 1, S-1MEF 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 09:00 ET | [8-K](/filings/0001493152-26-048644.md) | 5.07 Shareholder vote results | 0001493152-26-048644 |
| 2026-08-13 | 08:20 ET | [10-Q](/filings/0001493152-26-037594.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037594 |
| 2026-08-13 | 08:15 ET | [8-K](/filings/0001493152-26-037592.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037592 |
| 2026-06-16 | 16:36 ET | [10-K/A](/filings/0001493152-26-028902.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-028902 |
| 2026-05-15 | 08:20 ET | [10-Q](/filings/0001493152-26-023368.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023368 |
| 2026-05-15 | 08:20 ET | [8-K](/filings/0001493152-26-023367.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023367 |
| 2026-04-22 | 16:24 ET | [SCHEDULE 13D](/filings/0001104659-26-046851.md) | Ownership report, active investor | 0001104659-26-046851 |
| 2026-04-21 | 08:00 ET | [8-K](/filings/0001493152-26-018202.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018202 |
| 2026-03-27 | 17:16 ET | [8-K](/filings/0001493152-26-013266.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013266 |
| 2026-03-02 | 08:00 ET | [8-K](/filings/0001493152-26-008449.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008449 |
| 2026-02-26 | 08:20 ET | [10-K](/filings/0001493152-26-008130.md) | Annual report, period 2025-12-31 | 0001493152-26-008130 |
| 2026-02-26 | 08:05 ET | [8-K](/filings/0001493152-26-008129.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-008129 |
| 2025-12-18 | 08:05 ET | [8-K](/filings/0001493152-25-028283.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028283 |
| 2025-10-16 | 08:21 ET | [10-Q](/filings/0001493152-25-018256.md) | Quarterly report, period 2025-09-30 | 0001493152-25-018256 |
| 2025-10-16 | 08:05 ET | [8-K](/filings/0001493152-25-018252.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-018252 |
| 2025-08-06 | 08:20 ET | [10-Q](/filings/0001641172-25-022357.md) | Quarterly report, period 2025-06-30 | 0001641172-25-022357 |
| 2025-08-06 | 08:05 ET | [8-K](/filings/0001641172-25-022354.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022354 |
| 2025-06-16 | 16:15 ET | [8-K](/filings/0001641172-25-015249.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001641172-25-015249 |
| 2025-05-15 | 08:20 ET | [10-Q](/filings/0001641172-25-010533.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010533 |
| 2025-05-15 | 08:05 ET | [8-K](/filings/0001641172-25-010525.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001641172-25-010525 |
| 2025-04-10 | 16:15 ET | [8-K](/filings/0001641172-25-003620.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 9.01 Financial statements and exhibits | 0001641172-25-003620 |
| 2025-04-08 | 16:05 ET | [8-K](/filings/0001641172-25-003216.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-003216 |
| 2025-03-21 | 08:20 ET | [10-K](/filings/0001493152-25-011084.md) | Annual report, period 2024-12-31 | 0001493152-25-011084 |
| 2025-03-21 | 08:05 ET | [8-K](/filings/0001493152-25-011082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011082 |
| 2025-02-14 | 08:00 ET | [8-K](/filings/0001493152-25-006588.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-006588 |
| 2024-12-20 | 08:30 ET | [8-K](/filings/0001493152-24-050889.md) | 5.07 Shareholder vote results | 0001493152-24-050889 |
| 2024-11-13 | 09:00 ET | [8-K](/filings/0001493152-24-044986.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044986 |
| 2024-11-08 | 09:20 ET | [DEF 14A](/filings/0001493152-24-044179.md) | Proxy statement, period 2024-11-08 | 0001493152-24-044179 |
| 2024-11-08 | 08:20 ET | [10-Q](/filings/0001493152-24-044163.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044163 |
| 2024-11-08 | 08:05 ET | [8-K](/filings/0001493152-24-044160.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044160 |
| 2024-10-08 | 16:48 ET | [8-K](/filings/0001493152-24-040453.md) | 5.08 Item not in the standard list | 0001493152-24-040453 |
| 2024-08-13 | 09:20 ET | [10-Q](/filings/0001493152-24-031478.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031478 |
| 2024-08-13 | 09:05 ET | [8-K](/filings/0001493152-24-031477.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031477 |
| 2024-07-19 | 16:05 ET | [8-K](/filings/0001493152-24-028507.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-028507 |
| 2024-05-29 | 08:45 ET | [8-K](/filings/0001493152-24-021732.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021732 |
| 2024-05-15 | 09:00 ET | [8-K](/filings/0001493152-24-019558.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-019558 |
| 2024-05-10 | 09:20 ET | [10-Q](/filings/0001493152-24-018579.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018579 |
| 2024-05-10 | 09:05 ET | [8-K](/filings/0001493152-24-018576.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-018576 |
| 2024-03-28 | 09:21 ET | [10-K](/filings/0001493152-24-011630.md) | Annual report, period 2023-12-31 | 0001493152-24-011630 |
| 2024-03-28 | 09:05 ET | [8-K](/filings/0001493152-24-011627.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-011627 |
| 2024-03-13 | 06:03 ET | [8-K](/filings/0001493152-24-009751.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-009751 |
| 2024-03-04 | 16:06 ET | [8-K](/filings/0001493152-24-008705.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-008705 |
| 2024-01-08 | 09:00 ET | [8-K](/filings/0001493152-24-001667.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-001667 |
| 2023-11-09 | 09:20 ET | [10-Q](/filings/0001493152-23-040012.md) | Quarterly report, period 2023-09-30 | 0001493152-23-040012 |
| 2023-11-09 | 09:05 ET | [8-K](/filings/0001493152-23-040009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040009 |
| 2023-08-10 | 09:20 ET | [10-Q](/filings/0001493152-23-027468.md) | Quarterly report, period 2023-06-30 | 0001493152-23-027468 |
| 2023-08-10 | 09:05 ET | [8-K](/filings/0001493152-23-027464.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-027464 |
| 2023-07-13 | 16:05 ET | [8-K](/filings/0001493152-23-024462.md) | 5.07 Shareholder vote results | 0001493152-23-024462 |
| 2023-07-11 | 09:05 ET | [8-K](/filings/0001493152-23-024176.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-024176 |
| 2023-06-02 | 09:20 ET | [DEF 14A](/filings/0001493152-23-019879.md) | Proxy statement, period 2023-06-02 | 0001493152-23-019879 |

Page 1 of 6. [Older](/companies/pulm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 07:25 ET. No prices; not investment advice.